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Abstract
Background: Prion diseases are fatal and infectious neurodegenerative diseases af-
fecting humans and animals. Rabbits are one of the few mammalian species reported
to be resistant to infection from prion diseases isolated from other species (I. Vorberg
et al., Journal of Virology 77 (3), 2003-2009 (2003)). Thus the study of rabbit prion
protein structure to obtain insight into the immunity of rabbits to prion diseases is very
important.
Findings: The paper is a straight forward molecular dynamics simulation study of
wild-type rabbit prion protein (monomer cellular form) which apparently resists the
formation of the scrapie form. The comparison analyses with human and mouse prion
proteins done so far show that the rabbit prion protein has a stable structure. The
main point is that the enhanced stability of the C-terminal ordered region especially
helix 2 through the D177-R163 salt-bridge formation renders the rabbit prion protein
stable. The salt bridge D201-R155 linking helix 3 and helix 1 also contributes to the
structural stability of rabbit prion protein. The hydrogen bond H186-R155 partially
contributes to the structural stability of rabbit prion protein.
Conclusions: Rabbit prion protein was found to own the structural stability, the salt
bridges D177-R163, D201-R155 greatly contribute and the hydrogen bond H186-R155
partially contributes to this structural stability. The comparison of the structural sta-
bility of prion proteins from the three species rabbit, human and mouse showed that the
human and mouse prion protein structures were not affected by the removing these two
salt bridges. Dima et al. (Biophysical Journal 83, 1268-1280 (2002) and Proceedings
of the National Academy of Sciences of the United States of America 101, 15335-15340
(2004)) also confirmed this point and pointed out that “correlated mutations that re-
duce the frustration in the second half of helix 2 in mammalian prion proteins could
inhibit the formation of PrPSc”.
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1 Introduction
Prion diseases, including Creutzfeldt-Jakob disease (CJD), variant Creutzfeldt-Jakob
diseases (vCJD), Gerstmann-Stra¨ussler-Scheinker syndrome (GSS), Fatal Familial In-
somnia (FFI), Kuru in humans, scrapie in sheep, bovine spongiform encephalopathy
(BSE or ‘mad-cow’ disease) and chronic wasting disease (CWD) in cattle, etc., are
invariably fatal and highly infectious neurodegenerative diseases affecting humans and
animals. However, for treating all these diseases, there is no effective therapeutic ap-
proach ([Aguzzi et al., 2006, Prusiner, 1998, Weissmann, 2004]).
Many marvelous biological functions in proteins and DNA and their profound dy-
namic mechanisms ([chou, 1984a, 1984b, 1987, 1989, 1994, chou et al., 1988]) can be
revealed by studying their internal motions ([Chou et al., 1988]). Likewise, to really
understand the stability of rabbit prion molecules and their action mechanism, we
should consider not only the static structures concerned but also the dynamical in-
formation obtained by simulating their internal motions or dynamic process ([Wang
et al., 2009a, 2009b, 2009c, 2008a, 2008b, 2008c, 2009d, 2007a, 2007b, 2009e, 2009f,
2010]). Prion protein molecular dynamics (MD) simulation studies usually have been
done on the C-terminal structured region, some C-terminal mutants, copper binding
segments (e.g. HGGGW, GGGTH), and amyloid fibril segments (e.g. AGAAAAGA
[Zhang, 2010b, Zhang et al., 2010c]). This paper is doing the MD simulation studies
on the rabbit prion protein C-terminal structured region.
Rabbits are one of the few mammalian species reported to be resistant to infection
from prion diseases isolated from other species ([Vorberg et al., 2003]). Recently, the
NMR molecular structures of wild-type, mutant S173N and mutant I214V rabbit prion
proteins (124-228) were released into the Protein Data Bank ([Berman et al., 2000])
with PDB ID codes 2FJ3, 2JOH, 2JOM respectively. Zhang (2010a) studied these
NMR structures by MD simulations and simulation results at 450 K under low and
neutral pH environments confirmed the structural stability of wild-type rabbit prion
protein. However, the previous MD simulation results at 500 K under neutral pH envi-
ronment showed that wild-type rabbit prion protein (124-228) does not have more struc-
tural stability than human prion protein (125-228) (PDB ID code 1QLX) and mouse
prion protein (124-226) (PDB ID code 1AG2) but the opposite holds ([Zhang, 2009]).
In [Zhang, 2010a], the author did not carry on the MD simulations at 450 K un-
der low and neutral pH environments for human prion protein (125-228) and mouse
prion protein (124-226); this paper will do this work. Findings of this paper agree
with the findings of [Zhang, 2010a], but disagree with the conclusion of [Zhang, 2009].
In order to further confirm the findings, this paper will do longer simulations than
[Zhang, 2009, Zhang, 2010a].
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The differences between [Zhang, 2009; Zhang, 2010a] are at: (1) Zhang (2009) did
not do the simulations under low pH environments, but Zhang (2010a) did; (2) Zhang
(2009) did the simulations at 500 K, but Zhang (2010a) did the simulations at 450 K;
(3) Zhang (2009) did the simulations by Amber 8, but Zhang (2010a) by Amber 9; (4)
Zhang (2009) did not study any mutant of rabbit prion protein, but Zhang (2010a)
studied the mutants of rabbit prion protein; (5) Zhang (2009) studied human and
mouse prion proteins, but Zhang (2010a) did not study human and mouse prion pro-
teins; (6) In [Zhang, 2009] the time of equilibrations done in constant NPT ensembles
under Berendsen thermostat was 20 ns, but in [Zhang, 2010a] the equilibrations were
done in constant NPT ensembles under Langevin thermostat for 5 ns; the productions
for [Zhang, 2009] were under Berendsen thermostat at 500 K, but for [Zhang, 2010a]
the productions were under Langevin thermostat at 450 K.
The infectious prion protein (124-228) (PrPSc) is an abnormally folded form of the
normal cellular prion protein (124-228) (PrPC) and the conversion of PrPC to PrPSc
is believed to involve conformational change from a predominantly α-helical protein
(42% α-helix, 3% β-sheet) to a protein rich in β-sheets (30% α-helix, 43% β-sheet)
([Cappaia et al., 2004, Daude, 2004, Ogayar et al., 1998, Pan et al., 1993, Reilly, 2000]).
This paper studies the NMR structures of wild-type human, mouse, and rabbit prion
proteins by computer MD simulations, where the NMR structure of PrPC consists of
β-strand 1, α-helix 1, β-strand 2, α-helix 2 and α-helix 3. Simulation results of this
paper show that the salt bridges D177-R163, D201-R155 greatly contribute to the struc-
tural stability of rabbit prion protein. We also find that the hydrogen bond H186-R155
partially contributes to the structural stability of rabbit prion protein.
2 Materials and methods
Simulation initial structure for the rabbit prion protein was built on RaPrPC(124-
228) (PDB entry 2FJ3). Identical simulations were also done for human prion pro-
tein (HuPrPC(125-228)) and mouse prion protein (MoPrPC(124-226)). The initial
simulation structures of human and mouse prion proteins were built on PDB en-
tries 1QLX ([Berman et al., 2000, Zahn et al., 2000]) and 1AG2 ([Berman et al., 2000,
Riek et al., 1996]), respectively. Simulation methods are completely same as the ones
of [Zhang, 2010a]. 16 Cl-, 14 Cl-, 14 Cl-, and 5599 waters, 3836 waters, 5909 waters
were separately added for the human, mouse, rabbit prion proteins under low pH en-
vironment. The step size of 2 fs is typical for the SHAKE algorithm at 300 K. At 450
K, 1 fs was used as the step size. For prion proteins some MD works have been done
at 500 K (e.g. [El-Bastawissy et al., 2001, Sekijima et al., 2003, Shamsir et al., 2005,
Yang et al., 2005]); this paper does the MD simulations at 450 K and these simulations
are not physically relevant.
Simulations were done under low pH and normal pH environments respectively.
All the simulations were performed with the AMBER 9 package ([Case et al., 2006]),
with analysis carried out using functionalities in AMBER 9 and AMBER 7 CAR-
NAL ([Case et al., 2002]). Graphs were drawn by XMGRACE of Grace 5.1.21, DSSP
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([Kabsch et al., 1983]). The AMBER ff03 force field was used. The van der Waals
and electrostatic interactions were treated by SHAKE algorithm and PMEMD algo-
rithm with nonbonded cutoffs of 12 angstroms. The systems were surrounded with
TIP3PBOX water molecules and neutralized by sodium ions, and optimized to remove
bad hydrogen contacts. Then the systems were heated from 100 K to 450 K step by
step during 3 ns. The thermostat algorithm used is the Langevin thermostat algorithm
in constant NVT ensembles. Equilibrations were done in constant NPT ensembles
under Langevin thermostat for 5 ns. After equilibrations, production MD phase was
carried out at 450 K for 20 ns using constant pressure and temperature ensemble. All
the simulations were performed on the Tango facilities of the Victoria Partnership for
Advanced Computing of Australia (http://www.vpac.org).
3 Results and discussion
The MD simulations done at room temperature 300 K whether under neutral or low
pH environment display very little fluctuation and no variation among rabbit, human
and mouse prion proteins. At 450 K there are fluctuation and variation among rabbit,
human and mouse prion proteins, but their backbone atom RMSDs (root mean square
deviations) respectively calculated from their minimized structures and their radii of
gyrations do not have great difference even under low pH environment (Fig.s 1-2). Their
secondary structures under neutral pH environment at 450 K, under low (Fig. 3) and
neutral pH environments at 300 K, do not change very much either. However, the sec-
ondary structures under low pH environment at 450 K have great differences between
rabbit prion protein and human and mouse prion proteins (Fig.s 4-5): the α-helices of
rabbit prion protein were completely unfolded and began to turn into β-sheets but those
of human and mouse prion proteins were not changed very much. These results indi-
cate the C-terminal region of RaPrPC has lower thermostability than that of HuPrPC
and MoPrPC. Under the low pH environment, the salt bridges D177-R163, D201-R155
were removed (thus the free energies of the salt bridges changed the thermostability)
so that the structure nearby the central helices 1-3 was changed for rabbit prion protein.
There always exist salt bridges (where the oxygen-nitrogen distance cut-off calcu-
lated for the salt bridges is 3.2 angstroms) between D202-R156, D178-R164 for human
and mouse prion proteins, between D201-R155, D177-R163 for rabbit prion protein.
The disulfide bond between C178-C213 links the 2nd and 3rd α-helices and keeps sev-
eral strong salt bridges linked. The salt bridge between D177-R163 keeps the linkage
of the middle of α-helix 2 and the coil at β-sheet 2 to α-helix 2. The salt bridge be-
tween D201-R155 makes the 3rd and 1st α-helices linked. The salt link distances of
D177-R163 and D201-R155 are illustrated in Fig.s 6-8. Except for the short period
of break of the salt bridge N202-R156 of human prion protein during 8.5-10.5 ns, the
salt bridges are always occupying human, mouse, and rabbit prion proteins. Under
low pH environment, all these salt bridges were removed. They did not change the
secondary structures of human and mouse prion proteins very much. However, rab-
bit prion protein is very sensitive to the low pH environment: the remove of these
salt bridges led to the collapse of the stable helical structure of wild-type rabbit prion
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protein. Structural stability of a protein is determined by factors of hydrogen bond,
van der Waals force, hydrophobic interaction, and salt bridge; change from neutral
to low pH environments will break the salt bridges only. Thus, we might be able to
say that salt bridges D177-R163, D201-R155 greatly contribute to the structural sta-
bility of rabbit prion protein. RaPrPC(124-228) apparently resists the formation of
the scrapie form, and the enhanced stability of the C-terminal ordered region espe-
cially helix 2 through the D177-R163 salt-bridge formation renders the rabbit prion
protein stable. The analyses of human and mouse prion proteins agree with the re-
sults of [Dima et al., 2002, Dima et al., 2004], where human and mouse prion proteins
were showed lack of stability and correlated mutations that reduce the frustration in the
second half of helix 2 in mammalian prion proteins could inhibit the formation of PrPSc.
The MD simulation experience of the NMR structure of human prion protein vari-
ant D178N (PDB ID: 2K1D, released on 03-MAR-2009) ([Mills et al., 2009]) of the
author confirmed that the secondary structural performance of the D178N mutant un-
der neutral pH environment at 450 K is same as that of the wild-type rabbit prion
protein under low pH environment at 450 K. Though the salt bridge R163-D177 in the
structure of prion proteins spans only 14 residues and it should have a rather impact
on the local structure, human and mouse prion proteins do not have the stable local
structure kept by the salt bridge R164-D178. This agrees with experimental results of
[Liemann et al., 1999], which showed a reduced stability if D178 was mutated into N178
for human prion protein. The MD simulation experience of the homology structure of
rabbit prion protein of Zhang et al. (2006) also confirmed that rabbit prion protein
has a more stable structure than human and mouse prion proteins, and the salt bridge
and hydrogen bond between D177 and R163 plays a key important role to this stability.
Recently Zhong (2010) reported that for human prion protein (PDB entry 1QM0)
the mutation of H187 into R187 makes the hydrogen bond H187-R156 broken, and the
strong electrostatic repulsion between R187 and R156 drives both positively charged
side chains away from their original positions leaving their hydrophobic core to be sol-
vent accessible. For rabbit prion protein at 450 K under neutral pH environment, there
is the hydrogen bond H186-R155 during more than 26.44% time of the 20 ns production
trajectories; however, for mouse (PDB entry 1AG2) and human (PDB entry 1QLX)
prion proteins at 450 K under the neutral pH environment, the hydrogen bond between
H187 and R156 has been broken during the whole 20 ns production trajectories. The
hydrogen bond H186-R155 clearly partially contributes to the structural stability of
rabbit prion protein.
Besides pH deviations and the choice of temperatures, point mutations from wild-
type can identify more contributing factors for the extraordinary stability of rabbit
prion protein. Through the study of wild-type and its S173N variant, recently Wen
et al. (2010a) suggested that the ordered loop 165-172 and its interaction with helix
3, together with the unique distribution of surface electrostatic potential, significantly
contribute to the unique structural characteristics of RaPrPC; most recently, Wen et
al. (2010b) studied the I214V mutant of rabbit prion protein and suggested that this
mutation results in a prominent global shift of surface charge distribution and an in-
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crease of backbone flexibility on a ps-ns time scale. Sweeting et al. (2009) pointed
out the rabbit prion mutants of S170N, S174N, and S170N/S174N break the hydrogen
bond network of residues 170-174.
The choice of temperatures is important and the choosing 450 K for this paper is
very significant. At 300 K, the MD results display little difference among rabbit, human
and mouse prion protein structures whether under neutral or low pH environments. At
500 K, Zhang (2009) found that under neutral pH environment the structure of rabbit
is not more stable than these of human and mouse but the opposite holds. However, at
450 K, this present paper found that the structure of rabbit is much more stable than
these of human and mouse; this agrees with the experimental results of rabbit prion
protein and shows that the choosing 450 K of this paper is significant.
Recent experimental results on mouse and rabbit prion proteins showed that rabbit
specific residues surrounding the GPI anchor attachment site inhibit prion infection
([Nisbet et al., 2010]). We find rabbit prion protein has a C-terminal residue R227
forming a hydrogen bond/salt bridge network with other inner residues but mouse
prion protein has no such an arginine residue at the end of C-terminal.
4 Conclusion
The paper is a straight forward MD simulation study of rabbit prion protein (monomer
cellular form) which apparently resists the formation of the scrapie form. The analy-
ses of MD simulation results confirmed the structural stability of rabbit prion protein
under neutral pH environment. The main point is that the enhanced stability of the
C-terminal ordered region especially helix 2 through the D177-R163 salt-bridge forma-
tion renders the rabbit prion protein stable. The salt bridge D201-R155 linking helix
3 and helix 1 also contributes to the structural stability of rabbit prion protein. The
comparison of the structural stability of prion proteins from the three species rabbit,
human and mouse showed that the human and mouse prion protein structures were
not affected by the removing these two salt bridges. We also find that the hydrogen
bond H186-R155 partially contributes to the structural stability of rabbit prion protein.
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Figure 1: Backbone atom RMSD graphs for human, mouse, rabbit prion proteins.
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Figure 2: Radius Of Gyration graphs for human, mouse, rabbit prion proteins.
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Figure 3: Snapshots of human, mouse, and rabbit prion proteins at 300 K under low
pH environment.
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Figure 4: Snapshots of human, mouse, and rabbit prion proteins at 450 K under low
pH environment.
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Figure 5: Secondary structures of rabbit, human and mouse prion proteins (from up to
down) at 450 K under neutral and low (from left to right) pH environments. (red: α-
Helix, pink: pi- Helix, yellow: 310-Helix, green: β-Bridge, blue: β-Sheet, purple: Turn,
Black: Bend; x-axis: time (0 ns-20 ns), y-axis: residue numbers.)
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Figure 6: Salt Bridges of human prion protein at 450 K under neutral pH environment.
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Figure 7: Salt Bridges of mouse prion protein at 450 K under neutral pH environment.
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Figure 8: Salt Bridges of rabbit prion protein at 450 K under neutral pH environment.
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